Related references
Note: Only part of the references are listed.AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach et al.
HEPATOLOGY (2018)
Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up
J. -H. Lee et al.
JOURNAL OF HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Autologous transplantation of cytokine-induced killer cells as an adjuvant therapy for hepatocellular carcinoma in Asia: an update meta-analysis and systematic review
Xiu-Rong Cai et al.
ONCOTARGET (2017)
Synergistic effect of cytokine-induced killer cell with valproate inhibits growth of hepatocellular carcinoma cell in a mouse model
Dong Hyeon Lee et al.
CANCER BIOLOGY & THERAPY (2017)
A randomized controlled trial on patients with or without adjuvant autologous cytokine-induced killer cells after curative resection for hepatocellular carcinoma
Li Xu et al.
ONCOIMMUNOLOGY (2016)
Immune checkpoint inhibitors enhance cytotoxicity of cytokine-induced killer cells against human myeloid leukaemic blasts
Su Li Poh et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Profiling the dynamic expression of checkpoint molecules on cytokine-induced killer cells from non-small-cell lung cancer patients
Lin Zhang et al.
ONCOTARGET (2016)
Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma
Joon Hyeok Lee et al.
GASTROENTEROLOGY (2015)
NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype
Erik Ames et al.
JOURNAL OF IMMUNOLOGY (2015)
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
Jordi Bruix et al.
LANCET ONCOLOGY (2015)
Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression-free survival for patients with hepatocellular carcinoma
Jiuwei Cui et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
A randomized phase II study of autologous cytokine-induced killer cells in treatment of hepatocelluar carcinoma
Xiaozhou Yu et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2014)
Clinical use of dendritic cells for cancer therapy
Sebastien Anguille et al.
LANCET ONCOLOGY (2014)
Serum Insulin-like Growth Factor-I Level Is an Independent Predictor of Recurrence and Survival in Early Hepatocellular Carcinoma: A Prospective Cohort Study
Eun Ju Cho et al.
CLINICAL CANCER RESEARCH (2013)
STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients
David Vasquez-Dunddel et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Human NK Cells Selective Targeting of Colon Cancer-Initiating Cells: A Role for Natural Cytotoxicity Receptors and MHC Class I Molecules
Rossana Tallerico et al.
JOURNAL OF IMMUNOLOGY (2013)
Human Glioblastoma Stem-Like Cells are More Sensitive to Allogeneic NK and T Cell-Mediated Killing Compared with Serum-Cultured Glioblastoma Cells
Tony Avril et al.
BRAIN PATHOLOGY (2012)
Efficacy of transcatheter arterial chemoembolization combined with cytokine-induced killer cell therapy on hepatocellular carcinoma: a comparative study
Ming-Zhi Hao et al.
Chinese Journal of Cancer (2012)
Hepatocellular carcinoma-specific immunotherapy with synthesized α1,3-galactosyl epitope-pulsed dendritic cells and cytokine-induced killer cells
Ying Qiu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Recurrence After Curative Resection of Early Gastric Cancer
Ho Geun Youn et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
The properties of tumor-initiating cells from a hepatocellular carcinoma patient's primary and recurrent tumor
Xiao-Lan Xu et al.
CARCINOGENESIS (2010)
Low-dose Cyclophosphamide Treatment Impairs Regulatory T Cells and Unmasks AFP-specific CD4+ T-cell Responses in Patients With Advanced HCC
Tim F. Greten et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses
Silke Paust et al.
NATURE IMMUNOLOGY (2010)
A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma
Hui Dong et al.
DIGESTIVE AND LIVER DISEASE (2009)
Cytokine-induced memory-like natural killer cells
Megan A. Cooper et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma
Miny Samuel et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2009)
Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion
Anne-Sophie Dugast et al.
JOURNAL OF IMMUNOLOGY (2008)
Minimally invasive treatment combined with cytokine-induced killer cells therapy lower the short-term recurrence rates of hepatocellular carcinomas
De-Sheng Weng et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Design and endpoints of clinical trials in hepatocellular carcinoma
Josep M. Llovet et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Recurrence after liver resection for hepatocellular carcinoma: Risk factors, treatment, and outcomes
Shimul A. Shah et al.
SURGERY (2007)
Management of hepatoceullular carcinoma
J Bruix et al.
HEPATOLOGY (2005)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials
JD Schwartz et al.
LANCET ONCOLOGY (2002)
Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis
L Bolondi et al.
GUT (2001)
Engineering hematopoietic grafts: Purified allogeneic hematopoietic stem cells plus expanded CD8(+) NK-T cells in the treatment of lymphoma
MR Verneris et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2001)
Selective bystander proliferation of memory CD4+ and CD8+ T cells upon NK T or T cell activation
G Eberl et al.
JOURNAL OF IMMUNOLOGY (2000)
Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial
T Takayama et al.
LANCET (2000)
Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma
YJ Chen et al.
GASTROENTEROLOGY (2000)
Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience
MF Yuen et al.
HEPATOLOGY (2000)
Share Paper
